AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on November 16, 2026

Merck KGaA, Darmstadt, Germany Signs Definitive Agreement to Acquire Rapid Micro Biosystems, Advancing Automation in Pharmaceutical Quality Control
Rapid Micro Biosystems Reports Third Quarter 2026 Financial Results
Rapid Micro Biosystems Signs Definitive Agreement to be Acquired by Merck KGaA, Darmstadt, Germany
Lantheus Presents Data from Two Pivotal Phase 3 Studies of TAUKLARIFY (Florquinitau F 18 Injection) PET Imaging in Early Alzheimer’s Disease
HealthEdge Introduces AI Strategy to Protect Health Plans From Unpredictable AI Costs
Nano Dimension Announces Divestiture of Global Inkjet Systems to QTREX Quantum in $16 Million Equity Transaction
AI-Driven Mobile Genomics Poised for Disruption as Edge Computing and Portable Sequencing Converge
MACOM Honored by Massachusetts Legislators
Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements
Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Akebia Enters into Term Loan Facility with Symbiotic Capital Worth Up to $140 Million
Corbus Pharmaceuticals presents Phase 1b CANYON-1 clinical trial data for CRB-913 at ObesityWeek® 2026
Trapped by Design: 50% of Enterprises Run Workloads in the Wrong Place
Arexera Therapeutics Highlights Potentially Best-in-Class Preclinical Profile and Initiates Clinical Development for ATL-101 in Huntington’s Disease
Rejuvenate Biomed Completes Last Patient Visit in Phase 2 Trial of RJx-01 in COPD-Related Muscle Weakness and Advances Regulatory Discussions for Sarcopenia

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.